Q3FY19 results were a mixed bag with revenues and EBITDA above I-direct estimates while net profit was lower than I-direct estimates due to higher depreciation and tax rate Revenues grew 32.2% YoY to | 732 crore (I-direct estimate: | 713 crore) mainly due to consolidation of Health City Cayman Islands (Cayman)and ramp up in new hospitals EBITDA margins improved 136 bps YoY to 10.6% (I-direct estimate: 10.1%) mainly due to lower other expenditure. EBITDA grew 51.5%...